Liver Metastasis–Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients
Grace Lee(Harvard University), Jennifer Y. Wo(Massachusetts General Hospital), Kimberly R. Gergelis(Mayo Clinic in Arizona), Colin D. Weekes(Massachusetts General Hospital), Andrzej Niemierko(Harvard University), Daniel W. Kim(Massachusetts General Hospital), Theodore S. Hong(Massachusetts General Hospital), Christopher L. Hallemeier(Mayo Clinic in Arizona), Amanda Jeanette Koong(Stanford University), Michael G. Haddock(Mayo Clinic in Arizona), Daniel T. Chang(National Tsing Hua University), Dawn Owen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Diego A.S. Toesca(Stanford University), Oluwadamilola T. Oladeru(Jacksonville College)
Cited by 16
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746